KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Q3 2025 value amounting to $8.1 million.

  • Acadia Pharmaceuticals' Other Working Capital Changes rose 4781.58% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 3148.53%. This contributed to the annual value of $16.6 million for FY2024, which is 623.41% down from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Other Working Capital Changes of $8.1 million as of Q3 2025, which was up 4781.58% from $44000.0 recorded in Q2 2025.
  • Acadia Pharmaceuticals' Other Working Capital Changes' 5-year high stood at $19.9 million during Q3 2023, with a 5-year trough of -$5.6 million in Q2 2023.
  • In the last 5 years, Acadia Pharmaceuticals' Other Working Capital Changes had a median value of $44000.0 in 2025 and averaged $1.4 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 29867.65% in 2021, then soared by 110120.79% in 2023.
  • Quarter analysis of 5 years shows Acadia Pharmaceuticals' Other Working Capital Changes stood at -$1.4 million in 2021, then tumbled by 40.89% to -$2.0 million in 2022, then skyrocketed by 158.3% to $1.1 million in 2023, then skyrocketed by 262.05% to $4.1 million in 2024, then skyrocketed by 96.59% to $8.1 million in 2025.
  • Its Other Working Capital Changes stands at $8.1 million for Q3 2025, versus $44000.0 for Q2 2025 and -$3.0 million for Q1 2025.